LifeVantage announces closing of LoveBiome acquisition

LifeVantage (LFVN) announced the closing of its previously announced acquisition of LoveBiome. Under the terms of the completed transaction, LifeVantage has acquired LoveBiome’s critical operating assets essential to the microbiome health business, including the retention of key LoveBiome personnel. “We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Olsen and the LoveBiome team to accelerate growth by leveraging their innovative microbiome solutions with our proven Activation technologies as one LifeVantage,” said Steve Fife, President and CEO of LifeVantage. “This strategic transaction expands our product portfolio into the rapidly growing gut health market while also broadening our reach in key markets including the US, Taiwan, and Europe, underscoring our deep commitment to our mission of offering people around the world a better path to wellness through Activation.”